Back to search
NL

NL · NL · NL-431f3090108f

Neoatricon 4,5 mg/ml oplossing voor infusie

ATC C01CA04

Last synced from CBG-MEB (Netherlands) on

Identification

ManufacturerBrePco Biopharma Limited
CountryNL (NL)
ATC codeC01CA04
Dispensing
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026

Packs · 1

  • cbg_meb_id
    EU/1/24/1804

Annotations

No annotations yet.

Raw payload (JSON)
{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/neoatricon-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Dopamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130408",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMMETABISULFIET (E 223)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "DOPAMINE HYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/05/27",
  "procedure_number": "EMEA/H/C/006044",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1804",
  "additional_monitoring": "N"
}

Related drugs

Other records sharing ATC code C01CA04.

Access this data programmatically

Query Neoatricon 4,5 mg/ml oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.